OBJECTIVE: Gypsies (or Roma) recently experienced a transition from a traditional to a Westernized lifestyle. Although mortality in this population is 4-fold higher compared with non-Gypsies, very limited information is available on their morbidity especially with regard to non-communicable diseases. Our aim was to determine the prevalence of type 2 diabetes mellitus (T2DM), metabolic syndrome and cardiovascular diseases in Gypsies and non-Gypsies living in the same region of southern Slovakia. MATERIALS AND METHODS: We examined 156 Gypsies and 501 non-Gypsies who participated in a population survey. Age- and sex-standardized prevalence rates were computed for each of the following: T2DM, obesity, hyperlipidemia, hypertension, hyperinsulinemia, elevated albumin/creatinine ratio (ACR), metabolic syndrome and cardiovascular disease. RESULTS: Age-sex standardized prevalence of T2DM was 30% (95% CI=22-39) in Gypsies and 10% (8-13, P=0.0001 for comparison of ethnic groups) in non-Gypsies. Corresponding prevalence of the other variables are: 65% (56-74) and 30% (26-34, P=0.0001) for obesity, 69% (61-76) and 59% (54-63, P=0.04) for hypercholesterolemia, 66% (59-74) and 39% (35-43, P=0.009) for hypertriglyceridemia, 49% (42-56) and 43% (39-47, P=0.1) for hypertension, 33% (26-50) and 8% (2-14, P=0.002) for hyperinsulinemia, 16% (9-22) and 5% (3-7, P=0.0001) for elevated ACR, 20% (12-27) and 4% (3-6, P=0.0001) for metabolic syndrome and 35% (28-43) and 26% (22-29, P=0.004) for cardiovascular disease. CONCLUSIONS: Compared with non-Gypsies, Gypsies had a much higher prevalence of T2DM, metabolic syndrome and cardiovascular disease, which may contribute to their higher mortality.
OBJECTIVE: Gypsies (or Roma) recently experienced a transition from a traditional to a Westernized lifestyle. Although mortality in this population is 4-fold higher compared with non-Gypsies, very limited information is available on their morbidity especially with regard to non-communicable diseases. Our aim was to determine the prevalence of type 2 diabetes mellitus (T2DM), metabolic syndrome and cardiovascular diseases in Gypsies and non-Gypsies living in the same region of southern Slovakia. MATERIALS AND METHODS: We examined 156 Gypsies and 501 non-Gypsies who participated in a population survey. Age- and sex-standardized prevalence rates were computed for each of the following: T2DM, obesity, hyperlipidemia, hypertension, hyperinsulinemia, elevated albumin/creatinine ratio (ACR), metabolic syndrome and cardiovascular disease. RESULTS: Age-sex standardized prevalence of T2DM was 30% (95% CI=22-39) in Gypsies and 10% (8-13, P=0.0001 for comparison of ethnic groups) in non-Gypsies. Corresponding prevalence of the other variables are: 65% (56-74) and 30% (26-34, P=0.0001) for obesity, 69% (61-76) and 59% (54-63, P=0.04) for hypercholesterolemia, 66% (59-74) and 39% (35-43, P=0.009) for hypertriglyceridemia, 49% (42-56) and 43% (39-47, P=0.1) for hypertension, 33% (26-50) and 8% (2-14, P=0.002) for hyperinsulinemia, 16% (9-22) and 5% (3-7, P=0.0001) for elevated ACR, 20% (12-27) and 4% (3-6, P=0.0001) for metabolic syndrome and 35% (28-43) and 26% (22-29, P=0.004) for cardiovascular disease. CONCLUSIONS: Compared with non-Gypsies, Gypsies had a much higher prevalence of T2DM, metabolic syndrome and cardiovascular disease, which may contribute to their higher mortality.
Authors: Adriana Sudzinova; Jaroslav Rosenberger; Roy E Stewart; Jitse P van Dijk; Sijmen A Reijneveld Journal: Int J Public Health Date: 2015-12-12 Impact factor: 3.380
Authors: Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel Journal: Endocr Rev Date: 2008-10-29 Impact factor: 19.871
Authors: Benjamin Cook; Geoffrey Ferris Wayne; Anne Valentine; Anna Lessios; Ethan Yeh Journal: Int J Public Health Date: 2013-10-05 Impact factor: 3.380
Authors: Zuzana Skodova; Jitse P van Dijk; Iveta Nagyova; Jaroslav Rosenberger; Daniela Ondusova; Martin Studencan; Sijmen A Reijneveld Journal: Int J Public Health Date: 2010-05-15 Impact factor: 3.380
Authors: Katalin Sumegi; Balazs Duga; Bela I Melegh; Zsolt Banfai; Erzsebet Kovesdi; Anita Maasz; Bela Melegh Journal: Pathol Oncol Res Date: 2017-01-19 Impact factor: 3.201
Authors: Miklos Z Molnar; Robert M Langer; Adam Remport; Maria E Czira; Katalin Rajczy; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Marta Novak; Istvan Mucsi; Laszlo Rosivall Journal: Int Urol Nephrol Date: 2011-11-25 Impact factor: 2.370
Authors: A Sudzinova; I Nagyova; M Studencan; J Rosenberger; Z Skodova; H Vargova; B Middel; S A Reijneveld; J P van Dijk Journal: Int J Public Health Date: 2013-03-31 Impact factor: 3.380